Janumet and Occipital neuralgia - a phase IV clinical study of FDA data
No or few reports are found.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No or few reports are found.
What is Janumet?
Janumet has active ingredients of metformin hydrochloride; sitagliptin phosphate. It is used in diabetes. Currently, eHealthMe is studying from 24,143 Janumet users.
What is Occipital Neuralgia?
Occipital neuralgia (condition characterized by chronic pain in the upper neck) is found to be associated with 680 drugs and 420 conditions by eHealthMe. Currently, we are studying 1,195 people who have Occipital neuralgia.
Do you take Janumet and have Occipital neuralgia?Check whether Occipital neuralgia is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Janumet side effects by duration, gender and age:
- Janumet side effects (24,143 reports)
Occipital neuralgia treatments and more:
- Occipital neuralgia (1,195 reports)
All the drugs that are associated with Occipital neuralgia:
All the conditions that are associated with Occipital neuralgia:
How the study uses the data?
The study uses data from the FDA. It is based on metformin hydrochloride; sitagliptin phosphate (the active ingredients of Janumet) and Janumet (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Buprenorphine and Bradycardia - a second ago
- Vinorelbine and Lower Limb Fracture - 2 seconds ago
- Penlac and Fainting - 3 seconds ago
- Difluprednate and Brimonidine drug interaction - 6 seconds ago
- Tysabri and Antinuclear Antibody Increased - 16 seconds ago
- Baclofen and Ureteric Obstruction - 22 seconds ago
- Seroquel and Psychomotor Hyperactivity - 35 seconds ago
- Excedrin and Nasal Discomfort - 44 seconds ago
- Metoprolol Tartrate and Muscle Rupture - 45 seconds ago
- Darvocet and Spinal Osteoarthritis - 50 seconds ago